Literature DB >> 1545573

Outcome of recipients of bone marrow transplants who require intensive-care unit support.

B Afessa1, A Tefferi, H C Hoagland, L Letendre, S G Peters.   

Abstract

To determine the outcome and prognostic factors associated with bone marrow transplantation (BMT), we reviewed the clinical course of 35 adult recipients of such a transplant who were admitted to our intensive-care unit (ICU). This constituted 24% of patients who underwent BMT for treatment of hematologic disorders during the study period. The reasons for admission to the ICU were postsurgical care in 5, respiratory failure in 25, shock in 4, and renal failure in 1. The in-hospital mortality was 20% for the postsurgical patients and 87% for the others. None of the postsurgical patients required mechanical ventilation, whereas 90% of the others did, and the associated mortality was 93%. Infection was the cause of the respiratory failure in all but 3 of the 25 patients and was associated with 95% mortality. Complications that involved multiple organs increased the mortality to 100%. No significant differences were found in age, sex, type of BMT, serologic tests for cytomegalovirus, history of graft-versus-host disease, conditioning regimen for BMT, and duration of stay in the ICU and the hospital between survivors and nonsurvivors. The APACHE II (acute physiology and chronic health evaluation) prognostic scoring system underestimated mortality and had no correlation with the duration of stay in the ICU or the hospital. Vasopressors, total parenteral nutrition, and transfusion of blood components in the ICU had no influence on the outcome. Open-lung biopsy was helpful in making specific diagnoses, and pulmonary artery catheters were used in most patients to guide therapy but did not improve survival.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1545573     DOI: 10.1016/s0025-6196(12)61310-x

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  22 in total

1.  A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).

Authors:  L Platon; L Amigues; P Ceballos; N Fegueux; D Daubin; N Besnard; R Larcher; L Landreau; C Agostini; S Machado; O Jonquet; K Klouche
Journal:  Bone Marrow Transplant       Date:  2015-11-16       Impact factor: 5.483

2.  Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT.

Authors:  R Benz; U Schanz; M Maggiorini; J D Seebach; G Stussi
Journal:  Bone Marrow Transplant       Date:  2013-09-23       Impact factor: 5.483

3.  Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit.

Authors:  Ulas D Bayraktar; Elizabeth J Shpall; Ping Liu; Stefan O Ciurea; Gabriela Rondon; Marcos de Lima; Marylou Cardenas-Turanzas; Kristen J Price; Richard E Champlin; Joseph L Nates
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

4.  Leucopenia is an independent predictor in cancer patients requiring invasive mechanical ventilation: a prognostic factor analysis in a series of 168 patients.

Authors:  F Vallot; M Paesmans; T Berghmans; J P Sculier
Journal:  Support Care Cancer       Date:  2003-01-22       Impact factor: 3.603

Review 5.  The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Authors:  Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares
Journal:  Intensive Care Med       Date:  2017-07-19       Impact factor: 17.440

6.  Engraftment syndrome and survival after respiratory failure post-bone marrow transplantation.

Authors:  D Marín; J Berrade; C Ferra; A Mateu; J Berlanga; A Salar; H Torrado; A Grañena; J L Ventura
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

7.  Outcome and prognostic indicators of patients with hematopoietic stem cell transplants admitted to the intensive care unit.

Authors:  Thanh N Huynh; S Sam Weigt; John A Belperio; Mary Territo; Michael P Keane
Journal:  J Transplant       Date:  2009-09-15

8.  Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience.

Authors:  Christelle Ferrà; Pilar Marcos; Maite Misis; Mireia Morgades; María-Luisa Bordejé; Albert Oriol; Natalia Lloveras; Juan-Manuel Sancho; Blanca Xicoy; Montserrat Batlle; Jordi Klamburg; Evarist Feliu; Josep-Maria Ribera
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

Review 9.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

Authors:  Jason A Coppell; Paul G Richardson; Robert Soiffer; Paul L Martin; Nancy A Kernan; Allen Chen; Eva Guinan; Georgia Vogelsang; Amrita Krishnan; Sergio Giralt; Carolyn Revta; Nicole A Carreau; Massimo Iacobelli; Enric Carreras; Tapani Ruutu; Tiziano Barbui; Joseph H Antin; Dietger Niederwieser
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-18       Impact factor: 5.742

10.  Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia.

Authors:  Didier Gruson; Frederic Vargas; Gilles Hilbert; Nam Bui; Thierry Maillot; Thierry Mayet; Odile Pillet; Genevieve Chene; Georges Gbikpi-Benissan
Journal:  Intensive Care Med       Date:  2004-03-30       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.